Sparton — Q3 FY2012 Earnings Presentation
12 slides from Sparton's earnings presentation, May 9, 2012
Slide 1: Fiscal 2012 Third Quarter Financial Results Conference Call
Exhibit 99.2 Fiscal 2012 Third Quarter Financial Results Conference Call February 8, 2012
Slide 2: Safe Harbor Statement
Safe Harbor Statement Certain statements herein constitute forward-looking statements within the meaning of the Securities Act of 1933, as amended and the Securities Exchange Act of 1934, as amended. When used herein, words such as “believe,” “expect,” “anticipate,” “project,” “plan,” “estimate,” “w
Slide 3: Today's Agenda
Today’s Agenda • 3rd Quarter Highlights • Fiscal 2012 Third Quarter Results • 3rd Quarter Segmented Operating Results • Liquidity & Capital Resources • New Business Awards • Outlook • Q&A 3
Slide 4: 3rd Quarter Highlights
rd 3 Quarter Highlights • Net sales increased by 9% from the same quarter last year (up 6%, net of acquisitions). • Adjusted net income increase to $0.19 per share versus an adjusted net income of $0.16 per share in the prior year quarter. • 12 new business programs were awarded of which 7 were with
Slide 5: Consolidated Financial Results
Consolidated Financial Results Fiscal 2012 Third Quarter (Reported) (Adjusted) (Adjusted) Quarter ended March 31, Quarter ended March 31, YoY 2012 2011 2012 2011 Variance Net Sales $ 55,048 $ 50,352 $ 55,048 $ 50,352 $ 4,696 Gross Profit 9,161 8,202 9,055 8,202 853 16.6% 16.3% 16.4% 16.3% Selling an
Slide 6: Sales & Gross Margin Results – Medical
Sales & Gross Margin Results Medical SALES 3 Months Ended March 31, 9 Months Ended March 31, SEGMENT 2012 % of Total 2011 % Change 2012 % of Total 2011 % Change Medical $ 27,046 49% $ 25,377 7% $ 82,533 51% $ 70,072 18% Complex Systems 12,812 23% 12,291 4% 37,921 23% 35,131 8% DSS 19,363 35% 16,350
Slide 7: Sales & Gross Margin Results – Complex Systems
Sales & Gross Margin Results Complex Systems SALES 3 Months Ended March 31, 9 Months Ended March 31, SEGMENT 2012 % of Total 2011 % Change 2012 % of Total 2011 % Change Medical $ 27,046 49% $ 25,377 7% $ 82,533 51% $ 70,072 18% Complex Systems 12,812 23% 12,291 4% 37,921 23% 35,131 8% DSS 19,363 35%
Slide 8: Sales & Gross Margin Results – Defense & Security Systems
Sales & Gross Margin Results Defense & Security Systems SALES 3 Months Ended March 31, 9 Months Ended March 31, SEGMENT 2012 % of Total 2011 % Change 2012 % of Total 2011 % Change Medical $ 27,046 49% $ 25,377 7% $ 82,533 51% $ 70,072 18% Complex Systems 12,812 23% 12,291 4% 37,921 23% 35,131 8% DSS
Slide 9: Liquidity & Capital Resources
Liquidity & Capital Resources Cash Availability ($ in '000) Mar-11 Jun-11 Sep-11 Dec-11 Mar-12 Cash and equivalents 26,119 24,550 26,984 30,610 26,682 LOC Availability 17,497 17,541 17,533 17,290 16,469 Total 43,616 42,091 44,517 47,900 43,151 Debt ($ in '000) Mar-11 Jun-11 Sep-11 Dec-11 Mar-12 Cred
Slide 10: New Business Awards
New Business Awards New Business Awards Potential Future Programs New Customers Annualized Revenue FY11 FY12 FY11 FY12 FY11 FY12 Q1 5 9 3 3 $ 2,200 $ 6,400 Q2 6 7 2 5 4,370 5,000 Q3 12 12 5 7 9,110 7,600 Q1-Q3 23 28 10 15 $ 15,680 $ 19,000 Q4 3 1 2,000 Total 26 11 $ 17,680 10
Slide 11: Fiscal 2012 Outlook
Fiscal 2012 Outlook • Focus on sustained profitability – Continue margin improvements in Complex Systems – Backfill Medical revenue losses with new business – Offset reduced U.S. Navy sonobuoy contracts with foreign sonobuoy sales – Continue improvements in operating performance through lean and qua
Slide 12: Q&A
A) iy SPsrtor Q&A 12